<DOC>
	<DOCNO>NCT02850146</DOCNO>
	<brief_summary>Approximately 50 participant enrol LEARN study ( NCT02488720 ) enrol LEARN-Tau study . The study design evaluate imaging characteristic 18F-AV-1451 participant enrol LEARN study expand safety database 18F-AV-1451 . The study run parallel LEARN study . In study , participant undergo three ( 3 ) 18F-AV-1451 PET scan 3 year period . Imaging visit occur start , middle end participant 's participation LEARN study ( correspond LEARN Visit 1 , Visit 4 6 , Visit 8 ) . The LEARN-Tau study ( 1 ) look change amount tau protein brain time , measure 18F-AV-1451 PET scan , ( 2 ) see tau protein brain old individual associate memory problem ( 3 ) evaluate safety 18F-AV-1451 side effect might associate . Site investigator , participant , study partner inform result 18F-AV-1451 PET scan result relate study ; however , finding may potential medical concern provide appropriate follow-up .</brief_summary>
	<brief_title>18F-AV-1451 PET Imaging Participants Enrolled LEARN Study</brief_title>
	<detailed_description />
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>Participants meet inclusion exclusion criterion LEARN study , addition : Male female consent currently enrol LEARN protocol ; Participants sign IRB approve informed consent form prior study procedure ; Participants opinion investigator tolerate PET scan procedure . Has condition , investigator 's opinion , could increase risk participant , limit participant 's ability tolerate experimental procedure , interfere analysis data . ( For example , participant chronic back pain might able lie still scan procedure . ) ; Has abnormal finding physical examination laboratory screen test suggest participant might condition could , opinion investigator , affect response radiopharmaceutical related testing procedure ; Is deem likely unable perform imaging procedure reason ; Has history risk factor torsades de pointes , include clinically significant finding ECG , take medication know prolong QT interval citalopram ≥ 40 mg/day , disopyramide , dofetilide , ibutilide , procainamide , quinidine , sotalol , bepridil ; A list restrict medication provide . Are females childbearing potential ( extremely unlikely LEARN eligible population age 65 85 ) surgically sterile , refrain sexual activity use reliable method contraception . Females childbearing potential must pregnant ( negative serum urine βhCG time screen negative serum urine βhCG image day ) breastfeed screen . Females must agree avoid become pregnant , females male must agree refrain sexual activity use reliable contraceptive method 24 hour follow administration 18FAV1451 Injection ; Males female partner pregnant childbearing potential must agree refrain sexual activity 24 hour follow administration 18FAV1451 Injection . Additionally , male must agree donate sperm 24 hour follow administration 18FAV1451 Injection ; Has hypersensitivity 18FAV1451 excipients .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>tau</keyword>
	<keyword>cognition</keyword>
	<keyword>longitudinal</keyword>
	<keyword>cognitive decline</keyword>
	<keyword>observational</keyword>
	<keyword>image</keyword>
</DOC>